Variations in the clinical practice of physicians managing Takayasu arteritis: A nationwide survey

Open Access Rheumatology: Research and Reviews

Volumn 9, Issue , 2017, Pages 91-99

  Barra, Lillian ^a   Liang, Patrick ^b   Benseler, Susanne M ^c   Cabral, David A ^d   Fifi Mah, Aurore ^c   Li, Yueyang ^a   Milman, Nataliya ^e   Twilt, Marinka ^c   Yacyshyn, Elaine ^f   Pagnoux, Christian ^g  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aortitis; Large vessel vasculitis; Physician practice patterns; Practice guidelines; Takayasu arteritis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; METHOTREXATE;

ADULT; AGED; AORTIC ARCH SYNDROME; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DISEASE ACTIVITY; DOCTOR PATIENT RELATION; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PRACTICE GUIDELINE; QUESTIONNAIRE; RELAPSE;

EID: 85020871986     PISSN: None     EISSN: 1179156X     Source Type: Journal    
DOI: 10.2147/OARRR.S132080     Document Type: Article

References (35)

1. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919-929.
2. Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005;34(4):284-292.
3. Mwipatayi BP, Jeffery PC, Beningfield SJ, et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005; 75(3):110-117.
4. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu’s disease). Circulation. 1989;80(3):429-437.
5. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000-1009.
6. Vanoli M, Daina E, Salvarani C et al; ITAA Study Group. Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Rheum. 2005;53(1):100-107.
7. Bicakcigil M, Aksu K, Kamali S, et al. Takayasu’s arteritis in Turkey-clinical and angiographic features of 248 patients. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S59-S64.
8. Moriwaki R, Numano F. Takayasu arteritis: follow-up studies for 20 years. Heart Vessels Suppl. 1992;7:138-145.
9. Yang L, Zhang H, Jiang X, et al. Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol. 2014;41(12):2439-2446.
10. Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu Arteritis observed from cross-country research in Japan: age and sex specificity. Circulation. 2015;132(18):1701-1709.
11. Brunner J, Feldman BM, Tyrrell PN, et al. Takayasu arteritis in children and adolescents. Rheumatology (Oxford). 2010;49(10):1806-1814.
12. JCS Joint Working Group. Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society. Circ J. 2011;75(2): 474-503.
13. Watts R, Al-Taiar A, Mooney J, Scott D, Macgregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009; 48(8):1008-1011.
14. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore). 1985;64(2):89-99.
15. Famorca L, Twilt M, Barra L, et al. Development of Canadian recommendations for the management of ANCA-Associated Vasculitides: results of the national needs assessment questionnaire. Open Rheumatol J. 2015;9:16-20.
16. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129-1134.
17. Ozen S, Pistorio A, Iusan SM, et al; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara
18. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798-806.
19. Misra R, Danda D, Rajappa SM, et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford). 2013;52(10):1795-1801.
20. Dolezalova P, Price-Kuehne FE, Özen S, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis. 2013;72(10):1628-1633.
21. Serra R, Butrico L, Fugetto F, et al. Updates in pathophysiology, diagnosis and management of takayasu arteritis. Ann Vasc Surg. 2016;35:210-225.
22. de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48-49:79-83.
23. Alibaz-Oner F, Direskeneli H. Update on Takayasu’s arteritis. Presse Med. 2015;44(6 Pt 2):e259-e265.
24. Hartlage GR, Palios J, Barron BJ, et al. Multimodality imaging of aortitis. JACC Cardiovasc Imaging. 2014;7(6):605-619.
25. Soussan M, Nicolas P, Schramm C, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and metaanalysis. Medicine (Baltimore). 2015;94(14):e622.
26. Tso E, Flamm SD, White RD, et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46(6):1634-1642.
27. Eshet Y, Pauzner R, Goitein O, et al. The limited role of MRI in long-term follow-up of patients with Takayasu’s arteritis. Autoimmun Rev. 2011; 11(2):132-136.
28. Goel R, Kumar TS, Danda D, et al. Childhood-onset Takayasu arteritis-experience from a tertiary care center in South India. J Rheumatol. 2014;41(6):1183-1189.
29. Szugye HS, Zeft AS, Spalding SJ. Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatr Rheumatol Online J. 2014;12:21.
30. Clemente G, Hilário MO, Len C, et al. Brazilian multicenter study of 71 patients with juvenile-onset Takayasu’s arteritis: clinical and angiographic features. Rev Bras Reumatol Engl Ed. 2016;56(2):145-151. Portuguese.
31. Keser G, Direskeneli H, Aksu K. Management of Takayasu arteritis: a systematic review. Rheumatology (Oxford). 2014;53(5):793-801.
32. de Franciscis S, Serra R, Luongo A, Sabino G, Puzziello A. The management of Takayasu’s arteritis: personal experience. Ann Vasc Surg. 2007;21(6):754-760.
33. Duarte MM, Geraldes R, Sousa R, Alarcão J, Costa J. Stroke and transient ischemic attack in Takayasu’s Arteritis: a systematic review and meta-analysis. Stroke Cerebrovasc Dis. 2016;25(4):781-791.
34. de Souza AW, Machado NP, Pereira VM, et al. Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circ J. 2010;74(6):1236-1241.
35. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68(3): 318-323.